A Study of Romosozumab (EVENITY®) in Postmenopausal Women in India With Osteoporosis at a High Risk of Fracture.

Clinical trial NCT06079476 · COMPLETED

Trial details

NCT number: NCT06079476
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Postmenopausal Osteoporosis

Start date: 2023-10-30
Primary completion: 2025-10-18
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.